Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reprogramming pacemakers enhances longevity and is cost-effective

G H Crossley1, D D Gayle, T W Simmons

  • 1Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1045, USA. gcrossle@bgsm.edu

Circulation
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal variation in incretin and insulin secretion in ponies in association with dietary macronutrients.

Veterinary journal (London, England : 1997)·2026
Same author

Studies in vitro of equine intestinal glucagon-like peptide-2 secretion.

Journal of equine veterinary science·2024
Same author

Evaluation of the diphenyl herbicide, oxyfluorfen, for effects on thyroid hormones in the juvenile rat.

Current research in toxicology·2024
Same author

Dr. Bailey's Case of Hepatic Colic.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Reevaluating the wave power-salt marsh retreat relationship.

Scientific reports·2023
Same author

Laryngectomy with a Tritube<sup>®</sup> and flow-controlled ventilation.

Anaesthesia reports·2021
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Reprogramming permanent pacemakers can significantly extend pulse generator longevity by over 60%. This cost-effective strategy optimizes battery life and reduces long-term healthcare expenses for patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • Permanent pacemaker pulse generators are often left at nominal settings post-implantation.
  • Advancements in lead technology have lowered chronic capture thresholds, enabling reduced output settings.
  • Lower settings can decrease battery drain and prolong generator lifespan.

Purpose of the Study:

  • To evaluate the impact of reprogramming permanent pacemakers on pulse generator longevity and associated costs.
  • To determine if optimizing pacemaker settings can extend device life beyond manufacturer predictions.

Main Methods:

  • A study of 180 patients undergoing permanent pacemaker implantation.
  • Analysis of 122 patients with 6-month follow-up and battery current measurement capabilities.

Related Experiment Videos

  • Comparison of predicted longevity at nominal implant settings versus final programmed settings.

    • Main Results:

    • Reprogramming extended estimated pulse generator longevity from 6.95 years to 11.16 years (a 64% increase).
    • The average extension in longevity was 4.25 years.
    • The cost-effectiveness was analyzed, showing an extended cost of $110 per patient, or $37 per year of extended life.

    Conclusions:

    • Reprogramming permanent pacemakers is an effective method to increase device longevity.
    • This optimization strategy is also cost-effective, offering significant savings.
    • Physician-determined final settings using standard safety margins are key to achieving these benefits.